RxBio's Unattributed - II Round

RxBio raised a round of funding on July 21, 2017.

RxBio is a biotech company based on a broad platform of novel and proprietary technology. Recently, a primary focus of RxBio has been developing its lead compound, Rx100, for use in mitigation of gast…

Articles about RxBio's Unattributed - II Round: